UMIN000018361
Efficacy and safety of high dose catechin-contained green tea in patients with NAFLD
Kanazawa University Department of Disease Control and Homeostasis·University Hospital Medical Information Network·dietary supplementRecruiting
Study focus
- Disease/Condition
- Nonalcoholic fatty liver disease (NAFLD)
- Study type
- Interventional
- Intervention type
- dietary supplement
Sponsor & location
- Primary sponsor
- Kanazawa University Department of Disease Control and Homeostasis
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Jul 21, 2015
- End date
- N/A
ICD-10 classifications
Liver disease, unspecifiedInflammatory liver disease, unspecifiedAlcoholic liver disease, unspecifiedAlcoholic fatty liverToxic liver disease, unspecified
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000018361
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000018361 through Pure Global AI's free database. This phase not specified trial is sponsored by Kanazawa University Department of Disease Control and Homeostasis and is currently Recruiting. The study focuses on Nonalcoholic fatty liver disease (NAFLD).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.